Mangoceuticals prices offering of 4M shares of common stock at 30c per share

Mangoceuticals priced its previously announced underwritten public offering of 4M shares of its common stock at a public offering price of 30c per share, for aggregate gross proceeds of $1.2M to the company, prior to deducting underwriting discounts and commissions and other offering expenses payable by the company. The offering is expected to close on or about December 19, subject to customary closing conditions. The company intends to use the net proceeds from the offering to finance the marketing and operational expenses associated with the planned marketing of its Mango ED and GROW hair growth products, to hire additional personnel to build organizational talent, to develop and maintain software, and for working capital and other general corporate purposes. Boustead Securities is acting as the sole underwriter for the offering.